My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

2.189 +0.139 (+6.76%)

Streaming Delayed Price Updated: 1:13 PM EST, Feb 10, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

38 39 Next >

38 Stocks Moving In Tuesday's Mid-Day Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI) climbed 329.2% to $10.43 after Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced a deal to acquire the company for $...

Via Benzinga

Why Is ToughBuilt Industries (TBLT) Stock Up 65% Today? ↗

April 19, 2022

ToughBuilt Industries (TBLT) stock is rocketing higher Tuesday following the release of the company's Q4 2021 earnings report.

Via InvestorPlace

Why Is Johnson & Johnson (JNJ) Stock in Focus Today? ↗

April 19, 2022

Johnson & Johnson (JNJ) stock is on the move Tuesday as investors react to the company's earnings report for the first quarter of 2022.

Via InvestorPlace

New York Times Report Fresh Allegations On Cassava's Simufilam Alzheimer's Trials, Shares Fall ↗

April 19, 2022

Cassava Sciences Inc (NASDAQ: SAVA) shares are shedding over 20% after

Via Benzinga

Why Is Cassava Sciences (SAVA) Stock Down Today? ↗

April 19, 2022

SAVA stock is tumbling after The New York Times reported that multiple experts are skeptical about Cassava's data and its main theory.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Tuesday ↗

April 19, 2022

On Tuesday, 242 companies hit new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company in terms of market cap to set a new 52-week low was...

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For April 19, 2022: Plug Power, Twitter, Cassava Sciences And More ↗

April 19, 2022

Benzinga’s “Daily Brief On Trending Tickers” features top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news items...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers Checkmate Pharmaceuticals (NASDAQ:CMPI) shares increased by 331.5% to $10.4 during Tuesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

April 19, 2022

Good morning! It's time to start off another busy day of trading with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

23 Stocks Moving in Tuesday's Pre-Market Session ↗

April 19, 2022

Gainers ToughBuilt Industries, Inc. (NASDAQ: TBLT) rose 44.9% to $0.2125 in pre-market trading as the company posted a narrower FY21 loss. Sharps Technology, Inc. (NASDAQ: STSS...

Via Benzinga

How Is The Market Feeling About Cassava Sciences Inc? ↗

April 13, 2022

Cassava Sciences Inc's (NASDAQ:SAVA) short percent of float has fallen 3.25% since its last report. The company recently reported that it has 10.93 million shares sold short,...

Via Benzinga

Cassava Sciences Is Worth Considering After Hitting Its Latest Trough ↗

April 11, 2022

The company has no debt and is cash rich. If it receives FDA approval for its Simufilam drug, the SAVA stock price will catapult.

Via InvestorPlace

51 Biggest Movers From Yesterday ↗

April 06, 2022

Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares surged 148.2% to close at $5.61 on Tuesday after the company announced that two of its designed mRNA molecules are...

Via Benzinga

Dear SOFI Stock Fans, Mark Your Calendars for May 1 ↗

April 05, 2022

SoFi Technologies (SOFI) stock is slipping on Tuesday and may see further falls this week ahead of student loan moratorium news.

Via InvestorPlace

This Is What Whales Are Betting On Cassava Sciences ↗

April 05, 2022

A whale with a lot of money to spend has taken a noticeably bullish stance on Cassava Sciences. Looking at options history for Cassava Sciences (NASDAQ:SAVA) we detected 14 strange trades.

Via Benzinga

Why Is Cassava Sciences (SAVA) Stock Down Today? ↗

April 05, 2022

Cassava Sciences (SAVA) stock is falling on Tuesday as investors react to a recent fireside chat held by CEO Remi Barbier.

Via InvestorPlace

Here's How Much You Would Have Made Owning Cassava Sciences Stock In The Last 5 Years ↗

April 04, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 29.74% on an annualized basis producing an average annual return of 43.85%. Currently, Cassava Sciences has a market...

Via Benzinga

R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development

March 31, 2022

Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...

Via FinancialNewsMedia

Risk-on Biotech Investors Should Buy Cassava Sciences ↗

March 30, 2022

SAVA stock is volatile but worthwhile after opinion shifts in its favor. Remember, it has a blockbuster Alzheimer's drug nearing launch.

Via InvestorPlace

Here's How Much $100 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today ↗

March 16, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 26.48% on an annualized basis. Buying $100 In SAVA: 5 years ago, an investor could have...

Via Benzinga

Keep Risk in Mind With Cassava Sciences Stock, but Don’t Dismiss Upside Potential ↗

March 15, 2022

A recent admission by management underscores the need to make SAVA stock, at best, a small, speculative position in your portfolio.

Via InvestorPlace

Cassava Sciences Is in a Bleak Midwinter Waiting for Spring and Better Days ↗

March 03, 2022

SAVA stock is driven by updates on clinical Phase 3 trials and lots of irrationality. Meanwhile, an FDA approval may take quite some time.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 02, 2022

Gainers Eargo (NASDAQ:EAR) shares rose 10....

Via Benzinga

Why Cassava Sciences Is Still a High-Risk Play ↗

February 25, 2022

As it's not set in stone that Cassava Sciences will be able to bring simulfilam to market, you should approach SAVA stock cautiously.

Via InvestorPlace

23 Stocks Moving in Wednesday's Pre-Market Session ↗

February 23, 2022

Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) rose 64.9% to $2.54 in pre-market trading after gaining around 5% on Tuesday. Roth Capital recently initiated coverage on the...

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

February 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Check Out What Whales Are Doing With SAVA ↗

February 11, 2022

Someone with a lot of money to spend has taken a bearish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...

Via Benzinga

Benzinga's Daily Brief On Trending Tickers For Feb. 11, 2022: Cassava Sciences, Cleveland Cliffs, GameStop, and More ↗

February 11, 2022

Benzinga’s “Daily Brief On Trending Tickers” highlights top-searched tickers from around the web and uses the Benzinga Pro platform to highlight recent news...

Via Benzinga

$1000 Invested In This Stock 5 Years Ago, Would Be Worth This Much ↗

February 11, 2022

Cassava Sciences (NASDAQ:SAVA) has outperformed the market over the past 5 years by 53.42% on an annualized basis.

Via Benzinga

Cassava Sciences Whale Trades Spotted ↗

February 09, 2022

Someone with a lot of money to spend has taken a bullish stance on Cassava Sciences (NASDAQ:SAVA). And retail traders should know. We noticed this today when the big position showed up on publicly...

Via Benzinga

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.